Zura Bio Ltd SEC filings ZURA
Zura Bio Ltd has 446 filings in SEC EDGAR's recent list, going back to Apr 8, 2021. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 27, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Nov 3, 2026 | — |
| S-3 | Shelf registration | Oct 27, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 27, 2026 | Oct 27, 2026 |
| 10-Q | Quarterly report | Oct 27, 2026 | Sep 30, 2026 |
| S-8 | Employee stock plan registration | Sep 30, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 17, 2026 | Aug 17, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 11, 2026 | Aug 11, 2026 |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 1, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 18, 2026 | Jun 17, 2026 |
| DEFA14A | Additional proxy material | May 22, 2026 | — |
| 8-K |
Current report
Officer or director change
|
May 22, 2026 | May 20, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 7, 2026 | May 7, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 23, 2026 | Apr 20, 2026 |
| 10-K | Annual report | Mar 19, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 19, 2026 | Mar 19, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2026 | Mar 10, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 5, 2026 | Mar 5, 2026 |
| 8-K/A | Amended current report | Feb 26, 2026 | Feb 24, 2026 |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Feb 26, 2026 | Feb 24, 2026 |
| 424B5 | Prospectus supplement | Feb 25, 2026 | — |
| 424B5 | Prospectus supplement | Feb 24, 2026 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 23, 2026 | Feb 21, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 11, 2026 | Feb 11, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 26, 2026 | Jan 20, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, Unregistered share sale, Other events
|
Jan 2, 2026 | Dec 29, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 17, 2025 | Dec 11, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 10, 2025 | Oct 8, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 30, 2025 | Sep 24, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 4, 2025 | Sep 4, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 20, 2025 | Aug 20, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 1, 2025 | Jun 25, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 4, 2025 | Jun 4, 2025 |
| UPLOAD | Letter from the SEC | Jun 3, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 27, 2025 | May 27, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 23, 2025 | May 21, 2025 |
| CORRESP | Letter to the SEC | May 22, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 20, 2025 | May 20, 2025 |
| UPLOAD | Letter from the SEC | May 8, 2025 | — |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| ARS | Annual report to shareholders | Apr 23, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 23, 2025 | May 21, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Apr 17, 2025 | Apr 16, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 25, 2025 | Mar 25, 2025 |
| 10-K | Annual report | Mar 25, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 25, 2025 | Mar 25, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 24, 2025 | Feb 24, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 23, 2024 | Dec 23, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 25, 2024 | Nov 25, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 14, 2024 | Nov 14, 2024 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 30, 2024 | Oct 30, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Oct 29, 2024 | Oct 23, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 18, 2024 | Oct 15, 2024 |
| EFFECT | Filing | Sep 17, 2024 | — |
| CORRESP | Letter to the SEC | Sep 16, 2024 | — |
| S-3/A | Form s-3/a | Sep 16, 2024 | — |
| ARS | Annual report to shareholders | Sep 13, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Sep 13, 2024 | — |
| DEF 14A | Proxy statement | Sep 13, 2024 | Oct 23, 2024 |
| S-3/A | Form s-3/a | Sep 11, 2024 | — |
| EFFECT | Filing | Sep 10, 2024 | — |
| EFFECT | Filing | Sep 10, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 10, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 9, 2024 | Sep 9, 2024 |
| POS AM | Filing | Sep 5, 2024 | — |
| POS AM | Filing | Sep 5, 2024 | — |
| S-3 | Shelf registration | Sep 3, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 3, 2024 | Sep 3, 2024 |
| 25-NSE | Delisting notice | Aug 27, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Aug 21, 2024 | Aug 15, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 14, 2024 | Aug 14, 2024 |
| 424B3 | Prospectus | Aug 13, 2024 | — |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 425 | Filing | Aug 12, 2024 | — |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Shareholder vote results, Other events
|
Aug 12, 2024 | Aug 12, 2024 |
| SC TO-I/A | Filing | Aug 9, 2024 | — |
| 425 | Filing | Aug 9, 2024 | — |
| 8-K |
Current report
Other events
|
Aug 9, 2024 | Aug 9, 2024 |
| EFFECT | Filing | Aug 8, 2024 | — |
| 424B3 | Prospectus | Aug 8, 2024 | — |
| CORRESP | Letter to the SEC | Aug 6, 2024 | — |
| CORRESP | Letter to the SEC | Jul 25, 2024 | — |
| SC TO-I/A | Filing | Jul 25, 2024 | — |
| S-4/A | Filing | Jul 25, 2024 | — |
| 425 | Filing | Jul 25, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Jul 25, 2024 | Jul 24, 2024 |
| UPLOAD | Letter from the SEC | Jul 19, 2024 | — |
| 425 | Filing | Jul 12, 2024 | — |
| 8-K |
Current report
Other events
|
Jul 12, 2024 | Jul 12, 2024 |
| SC TO-I | Filing | Jul 12, 2024 | — |
| S-4 | Registration for a merger or exchange | Jul 12, 2024 | — |
| 8-K/A |
Amended current report
Officer or director change
|
Jul 2, 2024 | Mar 24, 2024 |
| EFFECT | Filing | Jun 18, 2024 | — |
| POS AM | Filing | Jun 18, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 14, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 6, 2024 | Jun 6, 2024 |
| 424B3 | Prospectus | Jun 4, 2024 | — |
| EFFECT | Filing | Jun 3, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 3, 2024 | Jun 3, 2024 |
| 424B7 | Form 424b7 | May 31, 2024 | — |
| CORRESP | Letter to the SEC | May 30, 2024 | — |
| UPLOAD | Letter from the SEC | May 29, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 29, 2024 | May 29, 2024 |
| S-1 | Registration statement | May 24, 2024 | — |
| 10-Q/A | Amended quarterly report | May 15, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| D | Filing | May 6, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Apr 23, 2024 | Apr 18, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 8, 2024 | Apr 8, 2024 |
| 10-K | Annual report | Mar 28, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Mar 28, 2024 | Mar 24, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 11, 2024 | Mar 11, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 4, 2024 | Mar 4, 2024 |
| 8-K |
Current report
Auditor change
|
Feb 23, 2024 | Mar 29, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 2, 2024 | Feb 2, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 11, 2024 | Jan 11, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 8, 2024 | Jan 3, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 3, 2024 | Jan 3, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 6, 2023 | Nov 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 4, 2023 | Dec 4, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 14, 2023 | Nov 14, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 25, 2023 | Oct 24, 2023 |
| 424B7 | Filing | Oct 16, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Oct 3, 2023 | Jun 22, 2023 |
| EFFECT | Filing | Sep 14, 2023 | — |
| 424B3 | Prospectus | Sep 14, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 14, 2023 | Sep 12, 2023 |
| CORRESP | Letter to the SEC | Sep 12, 2023 | — |
| S-1/A | Amended registration statement | Sep 11, 2023 | — |
| CORRESP | Letter to the SEC | Sep 8, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 6, 2023 | — |
| S-1/A | Amended registration statement | Aug 25, 2023 | — |
| CORRESP | Letter to the SEC | Aug 24, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 17, 2023 | — |
| 8-K |
Current report
Results of operations
|
Aug 14, 2023 | Aug 14, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| CORRESP | Letter to the SEC | Aug 11, 2023 | — |
| S-1/A | Amended registration statement | Aug 11, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 28, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 27, 2023 | Jul 27, 2023 |
| CORRESP | Letter to the SEC | Jul 21, 2023 | — |
| S-1/A | Amended registration statement | Jul 21, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 23, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 23, 2023 | Jun 23, 2023 |
| S-8 | Employee stock plan registration | Jun 22, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 15, 2023 | Jun 14, 2023 |
| S-1 | Registration statement | Jun 14, 2023 | — |
| 8-K |
Current report
Unregistered share sale, Regulation FD disclosure
|
Jun 6, 2023 | Jun 5, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 2, 2023 | Jun 1, 2023 |
| DEF 14A | Proxy statement | May 19, 2023 | Jun 1, 2023 |
| 10-Q | Quarterly report | May 12, 2023 | Mar 31, 2023 |
| PRE 14A | Preliminary proxy statement | May 9, 2023 | May 8, 2023 |
| D | Filing | May 5, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
May 3, 2023 | Apr 26, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 27, 2023 | Apr 27, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 14, 2023 | Apr 14, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 10, 2023 | Apr 7, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 7, 2023 | Apr 6, 2023 |
| 8-K | Current report | Apr 6, 2023 | Apr 5, 2023 |
| 10-K | Annual report | Mar 28, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 28, 2023 | Mar 23, 2023 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change
|
Mar 24, 2023 | Mar 20, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 21, 2023 | Mar 20, 2023 |
| CERT | Filing | Mar 21, 2023 | — |
| 25 | Form 25 | Mar 20, 2023 | — |
| 8-A12B | Filing | Mar 20, 2023 | — |
| 425 | Filing | Mar 16, 2023 | — |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
Mar 16, 2023 | Mar 16, 2023 |
| 425 | Filing | Mar 15, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 15, 2023 | Mar 13, 2023 |
| 425 | Filing | Mar 10, 2023 | — |
| 8-K |
Current report
Material agreement, Other events
|
Mar 10, 2023 | Mar 8, 2023 |
| 425 | Filing | Mar 2, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 2, 2023 | Mar 2, 2023 |
| 424B3 | Prospectus | Mar 1, 2023 | — |
| SEC STAFF LETTER | Filing | Feb 28, 2023 | — |
| EFFECT | Filing | Feb 28, 2023 | — |
| CORRESP | Letter to the SEC | Feb 24, 2023 | — |
| S-4/A | Filing | Feb 23, 2023 | — |
| CORRESP | Letter to the SEC | Feb 22, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 22, 2023 | — |
| CORRESP | Letter to the SEC | Feb 17, 2023 | — |
| S-4/A | Filing | Feb 17, 2023 | — |
| SEC STAFF LETTER | Filing | Feb 14, 2023 | — |
| CORRESP | Letter to the SEC | Feb 10, 2023 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ZURA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- La Jolla, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1855644
- Former names
- JATT Acquisition Corp (until Mar 21, 2023)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.